Cargando…
Different drug approaches to COVID-19 treatment worldwide: an update of new drugs and drugs repositioning to fight against the novel coronavirus
According to the World Health Organization (WHO), in the second half of 2022, there are about 606 million confirmed cases of COVID-19 and almost 6,500,000 deaths around the world. A pandemic was declared by the WHO in March 2020 when the new coronavirus spread around the world. The short time betwee...
Autores principales: | Oliver, Josidel Conceição, Silva, Evandro Neves, Soares, Letícia Martins, Scodeler, Gislaine Cristina, Santos, Ana de Souza, Corsetti, Patrícia Paiva, Prudêncio, Carlos Roberto, de Almeida, Leonardo Augusto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791004/ https://www.ncbi.nlm.nih.gov/pubmed/36578829 http://dx.doi.org/10.1177/25151355221144845 |
Ejemplares similares
-
Current advancements and future prospects of COVID-19 vaccines and therapeutics: a narrative review
por: Sanyaolu, Adekunle, et al.
Publicado: (2022) -
Lymphadenopathy subsequent to Covishield (ChAdOx1 nCoV-19) Corona
virus vaccine: ultrasound findings and clinical implications
por: Sahoo, Soumya Swaroop, et al.
Publicado: (2022) -
Repositioned Drugs for COVID-19—the Impact on Multiple Organs
por: Chan, Christina, et al.
Publicado: (2021) -
Risk of congenital anomalies in pregnant users of statin drugs
por: Ofori, Benjamin, et al.
Publicado: (2007) -
COVID-19: Analysis of Drug Repositioning Practice
por: Savosina, P. I., et al.
Publicado: (2021)